tradingkey.logo

BIOAGE Labs Inc

BIOA
8.020USD
+0.190+2.43%
Market hours ETQuotes delayed by 15 min
287.52MMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q1
Total revenue
--2.05M
--2.41M
--1.45M
----
----
--0.00
Revenue
--2.05M
--2.41M
--1.45M
----
----
--0.00
Operating expenses
1.79%25.19M
--27.18M
39.68%17.90M
--25.36M
--24.75M
--12.81M
R&D expenses
-7.52%18.51M
--19.84M
19.18%11.11M
--19.23M
--20.02M
--9.32M
Depreciation, depletion, and amortization
----
--58.00K
--37.00K
--47.00K
--38.00K
----
Operating profit
6.51%-23.14M
---24.77M
-28.35%-16.45M
---25.36M
---24.75M
---12.81M
Net non-operating interest income (expenses)
Non-operating interest income
55.13%3.16M
--3.42M
186.57%3.71M
--4.09M
--2.04M
--1.30M
Non-operating interest expense
-61.60%149.00K
--201.00K
-79.05%255.00K
--319.00K
--388.00K
--1.22M
Special income (expenses)
86.27%-42.00K
---11.00K
122.87%59.00K
--457.00K
---306.00K
---258.00K
Income before tax
----
---21.56M
0.49%-12.93M
---21.13M
---23.41M
---12.99M
Income after tax
----
---21.56M
0.49%-12.93M
---21.13M
---23.41M
---12.99M
Net income from continuous operations
13.82%-20.17M
---21.56M
0.49%-12.93M
---21.13M
---23.41M
---12.99M
Net income attributable to controlling interests
13.82%-20.17M
---21.56M
0.49%-12.93M
---21.13M
---23.41M
---12.99M
Net income attributable to common shareholders
13.82%-20.17M
---21.56M
0.49%-12.93M
---21.13M
---23.41M
---12.99M
Basic earnings per share
17.87%-0.56
---0.60
95.36%-0.36
---0.52
---0.69
---7.76
Diluted earnings per share
17.87%-0.56
---0.60
95.36%-0.36
---0.52
---0.69
---7.76
Dividend per share
----
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
KeyAI